Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCEAN: PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
NCT06392295Phase 2Recruiting
- Sponsor
- University of Miami
- Start
- Jul 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by University of Miami. Primary endpoint: Progression-free Survival at 2 years. Started Jul 2024; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06392295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06392295.